March 3, 2020 / 11:05 AM / a month ago

BRIEF-Biofrontera In Agreement With Maruho To Sell Ameluz In East Asia And Oceania

March 3 (Reuters) - BIOFRONTERA AG:

* ENTERED INTO BINDING TERM SHEET WITH MARUHO CO., LTD.

* AGREEMENT COVERS COMMERCIALIZATION OF AMELUZ^(R) BY MARUHO IN EAST ASIA AND OCEANIA

* MARUHO IS TO MAKE AN UPFRONT PAYMENT TO BIOFRONTERA AG IN AMOUNT OF EUR 6 MILLION UPON SIGNING OF AGREEMENT

* AMELUZ^(R) WILL BE SUPPLIED BY BIOFRONTERA TO MARUHO AT COST PLUS 25%.

* AGREEMENT HAS A TERM OF 15 YEARS FROM START OF DISTRIBUTION IN RESPECTIVE COUNTRY.

* MARUHO WILL ALSO MAKE ROYALTY PAYMENTS AT AN INITIAL RATE OF 6%

* MARUHO WILL GRANT TO BIOFRONTERA A FREE AND UNLIMITED LICENSE FOR RESULTS OF RESEARCH AND DEVELOPMENT ACTIVITIES FOR COMMERCIALIZATION OUTSIDE EAST ASIA AND OCEANIA Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below